{
    "nct_id": "NCT04524273",
    "official_title": "A Randomized, Double-blind, Multicenter, Placebo-controlled Phase 3 Study With Open-label Period to Evaluate the Efficacy and Safety of Inebilizumab in Adults With Myasthenia Gravis",
    "inclusion_criteria": "1. Diagnosis of MG with anti-AChR or anti-MuSK antibody.\n2. MGFA Clinical Classification Class II, III, or IV.\n3. MG-ADL score of 6 or greater at screening and at randomization with > 50% of this score attributed to non-ocular items.\n4. QMG score of 11 or greater.\n5. Participants must be on:\n\n   1. Corticosteroids only, with no dose increase within 4 weeks prior to randomization, or\n   2. One allowed non-steroidal immunosuppressive therapy (IST), with continuous use for at least 6 months prior to randomization and no dose increase within 4 months prior to randomization, or\n   3. Combination of (1) corticosteroids with no dose increase within 4 weeks prior to randomization and (2) one allowed non-steroidal IST with continuous use for at least 6 months prior to randomization and no dose increase within 4 months prior to randomization.\n\nAllowed ISTs, alone or in combination with corticosteroids, are azathioprine, mycophenolate mofetil, and mycophenolic acid.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "1. Receipt of the following medications within the 4 weeks prior to Day 1:\n\n   1. Cyclosporine (except eye drops)\n   2. Tacrolimus (except topical)\n   3. Methotrexate\n2. Current use of:\n\n   1. Corticosteroids (Prednisone > 40 milligram (mg)/day or > 80 mg over a 2-day period (or equivalent dose of other corticosteroids).\n   2. Acetylcholinesterase inhibitors (pyridostigmine) > 480 mg/day) or unstable dose in the 2 weeks prior to Day 1.\n   3. Azathioprine > 3 mg/kilogram (kg)/day\n   4. Mycophenolate mofetil > 3 grams/day or mycophenolic acid > 1440 mg/day\n   5. Any IST, alone or in combination with corticosteroids, except for azathioprine, mycophenolate mofetil, and mycophenolic acid.",
    "miscellaneous_criteria": ""
}